Popular Boards
1 Mentions
Aravind Natarajan, Hao-Wei Su, Conor Heneghan | Frontiers in Physiology | (2022)
Key Takeaways
Sample Definition And Size
The study analyzed resting heart rate data from individuals diagnosed with COVID-19, utilizing wearable devices to monitor heart rate over several weeks. The exact sample size is not specified in the provided information.
Study Type
Observational study using wearable devices to monitor resting heart rate in individuals diagnosed with COVID-19 over several weeks.
Conflicts Of Interest
No conflicts of interest were declared by the authors.
Results Summary
The study found that resting heart rate in individuals with COVID-19 exhibited three phases: 1) an initial increase during symptom onset, with average peak increases of 1.8% for females and 3.4% for males; 2) a decrease reaching a minimum approximately 13 days after symptom onset; and 3) a subsequent increase reaching a second peak approximately 28 days from symptom onset, before returning to baseline around 112 days from symptom onset. These changes varied with disease severity.
Abstract
The COVID-19 disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become one of the worst global pandemics of the century. Wearable devices are well suited for continuously measuring heart rate. Here we show that the Resting Heart Rate is modified for several weeks following a COVID-19 infection. The Resting Heart Rate shows 3 phases: 1) elevated during symptom onset, with average peak increases relative to the baseline of 1.8% (3.4%) for females (males), 2) decrease thereafter, reaching a minimum on average ≈13 days after symptom onset, and 3) subsequent increase, reaching a second peak on average ≈28 days from symptom onset, before falling back to the baseline ≈112 days from symptom onset. All estimates vary with disease severity.
Referenced In
Created: Aug 31, 2025